Resistance to BRAF inhibition in BRAF V600E colorectal cancer is associated with PI3K/AKT activation and hypermethylation

被引：0
|
作者：
Mao, Muling [1 ]
Tsao, Lawrence [1 ]
Dayyani, Farshid [1 ]
Nanda, Vashisht Gopal Yennu [1 ]
Mills, Gordon [1 ]
Bollag, Gideon [2 ]
Davies, Michael [1 ]
Gallick, Gary [1 ]
Kopetz, Scott [1 ]
机构：
[1] MDACC, Houston, TX USA
[2] Plexxikon Inc, Berkeley, CA USA
来源：
CANCER RESEARCH | 2011年 / 71卷
关键词：
D O I：
10.1158/1538-7445.AM2011-LB-228
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LB-228
引用
收藏
页数：1
相关论文
共 50 条
  • [1] c-Met-Mediated Reactivation of PI3K/AKT Signaling Contributes to Insensitivity of BRAF(V600E) Mutant Thyroid Cancer to BRAF Inhibition
    Byeon, Hyung Kwon
    Na, Hwi Jung
    Yang, Yeon Ju
    Kwon, Hyeong Ju
    Chang, Jae Won
    Ban, Myung Jin
    Kim, Won Shik
    Shin, Dong Yeob
    Lee, Eun Jig
    Koh, Yoon Woo
    Yoon, Joo-Heon
    Choi, Eun Chang
    MOLECULAR CARCINOGENESIS, 2016, 55 (11) : 1678 - 1687
  • [2] BRAF, MEK and EGFR inhibition as treatment strategies in BRAF V600E metastatic colorectal cancer
    Ros, Javier
    Baraibar, Iosune
    Sardo, Emilia
    Mulet, Nuria
    Salva, Francesc
    Argiles, Guillem
    Martini, Giulia
    Ciardiello, Davide
    Cuadra, Jose Luis
    Tabernero, Josep
    Elez, Elena
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2021, 13
  • [3] BRAF V600E: PROGNOSTIC MARKER IN COLORECTAL CANCER
    Plestina, S.
    Rako, I.
    Jakic-Razumovic, J.
    Katalinic, D.
    Sertic, J.
    ANNALS OF ONCOLOGY, 2012, 23 : 86 - 86
  • [4] BRAF V600E Inhibition in Anaplastic Thyroid Cancer
    Rosove, Michael H.
    Peddi, Parvin F.
    Glaspy, John A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (07): : 684 - 685
  • [5] Combined inhibition of BRAF/ MEK and mTOR/Akt/PI3K pathways in BRAF-V600 mutated lung adenocarcinoma
    Hegedues, L.
    Idrizi, A.
    Okumus, O.
    Aigner, C.
    Hegedues, B.
    PNEUMOLOGIE, 2023, 77 : S92 - S93
  • [6] BRAF V600E confers resistance to cetuximab or panitumumab metastatic colorectal cancer
    Di Nicolantonio, F.
    Martini, M.
    Molinari, F.
    Bianchi, A. Sartore
    Arena, S.
    Saletti, P.
    Mazzucchelli, L.
    Frattini, M.
    Siena, S.
    Bardelli, A.
    EJC SUPPLEMENTS, 2008, 6 (12): : 81 - 81
  • [7] Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma
    Chong Sun
    Liqin Wang
    Sidong Huang
    Guus J. J. E. Heynen
    Anirudh Prahallad
    Caroline Robert
    John Haanen
    Christian Blank
    Jelle Wesseling
    Stefan M. Willems
    Davide Zecchin
    Sebastijan Hobor
    Prashanth K. Bajpe
    Cor Lieftink
    Christina Mateus
    Stephan Vagner
    Wipawadee Grernrum
    Ingrid Hofland
    Andreas Schlicker
    Lodewyk F. A. Wessels
    Roderick L. Beijersbergen
    Alberto Bardelli
    Federica Di Nicolantonio
    Alexander M. M. Eggermont
    Rene Bernards
    Nature, 2014, 508 : 118 - 122
  • [8] Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma
    Sun, Chong
    Wang, Liqin
    Huang, Sidong
    Heynen, Guus J. J. E.
    Prahallad, Anirudh
    Robert, Caroline
    Haanen, John
    Blank, Christian
    Wesseling, Jelle
    Willems, Stefan M.
    Zecchin, Davide
    Hobor, Sebastijan
    Bajpe, Prashanth K.
    Lieftink, Cor
    Mateus, Christina
    Vagner, Stephan
    Grernrum, Wipawadee
    Hofland, Ingrid
    Schlicker, Andreas
    Wessels, Lodewyk F. A.
    Beijersbergen, Roderick L.
    Bardelli, Alberto
    Di Nicolantonio, Federica
    Eggermont, Alexander M. M.
    Bernards, Rene
    NATURE, 2014, 508 (7494) : 118 - +
  • [9] BRAF V600E Immunohistochemistry in Colorectal Carcinoma
    Estrella, J. S.
    Tetzlaff, M. T.
    Kazen, C.
    Kopetz, S.
    Maru, D. M.
    Rashid, A.
    Hamilton, S. R.
    Broaddus, R. R.
    MODERN PATHOLOGY, 2014, 27 : 173A - 173A
  • [10] BRAF V600E Immunohistochemistry in Colorectal Carcinoma
    Estrella, J. S.
    Tetzlaff, M. T.
    Kazen, C.
    Kopetz, S.
    Maru, D. M.
    Rashid, A.
    Hamilton, S. R.
    Broaddus, R. R.
    LABORATORY INVESTIGATION, 2014, 94 : 173A - 173A
12345